533 related articles for article (PubMed ID: 12438277)
1. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
[TBL] [Abstract][Full Text] [Related]
2. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Ho R; Eggert A; Hishiki T; Minturn JE; Ikegaki N; Foster P; Camoratto AM; Evans AE; Brodeur GM
Cancer Res; 2002 Nov; 62(22):6462-6. PubMed ID: 12438236
[TBL] [Abstract][Full Text] [Related]
3. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
Zhang JH; Li AM; Chen S; Tong HX; Zhang KR; Zhang JH
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):47-50. PubMed ID: 18289471
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity.
Scala S; Wosikowski K; Giannakakou P; Valle P; Biedler JL; Spengler BA; Lucarelli E; Bates SE; Thiele CJ
Cancer Res; 1996 Aug; 56(16):3737-42. PubMed ID: 8706017
[TBL] [Abstract][Full Text] [Related]
5. Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB.
Evans AE; Kisselbach KD; Liu X; Eggert A; Ikegaki N; Camoratto AM; Dionne C; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):181-4. PubMed ID: 11464878
[TBL] [Abstract][Full Text] [Related]
6. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
Matsumoto K; Wada RK; Yamashiro JM; Kaplan DR; Thiele CJ
Cancer Res; 1995 Apr; 55(8):1798-806. PubMed ID: 7712490
[TBL] [Abstract][Full Text] [Related]
7. Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex.
Pillai A; Veeranan-Karmegam R; Dhandapani KM; Mahadik SP
J Neurochem; 2008 Nov; 107(4):941-51. PubMed ID: 18786174
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor protects cementoblasts from serum starvation-induced cell death.
Kajiya M; Shiba H; Fujita T; Takeda K; Uchida Y; Kawaguchi H; Kitagawa M; Takata T; Kurihara H
J Cell Physiol; 2009 Dec; 221(3):696-706. PubMed ID: 19711359
[TBL] [Abstract][Full Text] [Related]
9. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
Li Z; Jaboin J; Dennis PA; Thiele CJ
Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
[TBL] [Abstract][Full Text] [Related]
10. Ethanol inhibits brain-derived neurotrophic factor-mediated intracellular signaling and activator protein-1 activation in cerebellar granule neurons.
Li Z; Ding M; Thiele CJ; Luo J
Neuroscience; 2004; 126(1):149-62. PubMed ID: 15145081
[TBL] [Abstract][Full Text] [Related]
11. P53/PUMA are potential targets that mediate the protection of brain-derived neurotrophic factor (BDNF)/TrkB from etoposide-induced cell death in neuroblastoma (NB).
Hua Z; Zhan Y; Zhang S; Dong Y; Jiang M; Tan F; Liu Z; Thiele CJ; Li Z
Apoptosis; 2018 Aug; 23(7-8):408-419. PubMed ID: 29959561
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death.
Li Z; Zhang J; Liu Z; Woo CW; Thiele CJ
Cell Death Differ; 2007 Feb; 14(2):318-26. PubMed ID: 16778834
[TBL] [Abstract][Full Text] [Related]
13. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Brodeur GM
Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
[TBL] [Abstract][Full Text] [Related]
15. Truncated trkB receptors on nonneuronal cells inhibit BDNF-induced neurite outgrowth in vitro.
Fryer RH; Kaplan DR; Kromer LF
Exp Neurol; 1997 Dec; 148(2):616-27. PubMed ID: 9417837
[TBL] [Abstract][Full Text] [Related]
16. Subtoxic N-methyl-D-aspartate delayed neuronal death in ischemic brain injury through TrkB receptor- and calmodulin-mediated PI-3K/Akt pathway activation.
Xu J; Zhang QG; Li C; Zhang GY
Hippocampus; 2007; 17(7):525-37. PubMed ID: 17492691
[TBL] [Abstract][Full Text] [Related]
17. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-induced cytotoxicity is blocked by brain-derived neurotrophic factor activation of TrkB signal transduction path in neuroblastoma.
Jaboin J; Hong A; Kim CJ; Thiele CJ
Cancer Lett; 2003 Apr; 193(1):109-14. PubMed ID: 12691830
[TBL] [Abstract][Full Text] [Related]
19. PLCgamma signaling underlies BDNF potentiation of Purkinje cell responses to GABA.
Cheng Q; Yeh HH
J Neurosci Res; 2005 Mar; 79(5):616-27. PubMed ID: 15672445
[TBL] [Abstract][Full Text] [Related]
20. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness.
Cimmino F; Schulte JH; Zollo M; Koster J; Versteeg R; Iolascon A; Eggert A; Schramm A
Oncogene; 2009 May; 28(19):2015-23. PubMed ID: 19363525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]